Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.32 USD | -2.58% | -7.74% | -47.40% |
Apr. 15 | RBC Lowers Price Target on Nevro to $16 From $18, Keeps Sector Perform Rating | MT |
Apr. 11 | Mizuho Adjusts Price Target on Nevro to $16 From $20, Maintains Neutral Rating | MT |
Financials (USD)
Sales 2024 * | 441M | Sales 2025 * | 468M | Capitalization | 426M |
---|---|---|---|---|---|
Net income 2024 * | -96M | Net income 2025 * | -81M | EV / Sales 2024 * | 0.68 x |
Net cash position 2024 * | 125M | Net cash position 2025 * | 97.38M | EV / Sales 2025 * | 0.7 x |
P/E ratio 2024 * |
-4.39
x | P/E ratio 2025 * |
-5.29
x | Employees | 1,215 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.94% |
Latest transcript on Nevro Corp.
1 day | -2.58% | ||
1 week | -7.74% | ||
Current month | -21.61% | ||
1 month | -21.50% | ||
3 months | -35.79% | ||
6 months | -21.61% | ||
Current year | -47.40% |
Managers | Title | Age | Since |
---|---|---|---|
Kevin Thornal
CEO | Chief Executive Officer | 50 | 23-04-23 |
D. Grossman
CHM | Chairman | 63 | 19-03-18 |
Roderick MacLeod
DFI | Director of Finance/CFO | 57 | 20-06-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael DeMane
BRD | Director/Board Member | 67 | 11-03-16 |
Karen Prange
BRD | Director/Board Member | 60 | 19-12-16 |
D. Grossman
CHM | Chairman | 63 | 19-03-18 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.10% | 509 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 11.62 | -7.11% | 346,398 |
24-04-24 | 12.51 | -2.19% | 514,963 |
24-04-23 | 12.79 | +4.24% | 412,366 |
24-04-22 | 12.27 | +1.66% | 575,808 |
24-04-19 | 12.07 | -2.03% | 385,671 |
Delayed Quote Nyse, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.40% | 426M | |
-2.31% | 185B | |
-3.20% | 105B | |
-5.04% | 66.59B | |
+0.20% | 54.66B | |
+17.29% | 47.78B | |
+4.06% | 41.26B | |
+2.36% | 26.95B | |
+2.07% | 26.37B | |
+12.96% | 24.8B |
- Stock Market
- Equities
- NVRO Stock